A service of arranging or bringing about contact between an investment manager and an issuer or potential issuer.
WINTER SPRINGS, Fla., Oct. 26, 2023 -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2023 third quarter financial results before the market opens on Friday, November 3rd. IRADIMED management will host a conference call the same...
WINTER SPRINGS, Fla., Sept. 06, 2023 -- IRADIMED CORPORATION (the "Company") (NASDAQ: IRMD) today announced that the Company will be participating in two upcoming investor conferences. Iradimed management is scheduled to participate in investor meetings at the H.C....
Reports record revenue of $16.1 million for the second quarter of 2023GAAP diluted EPS of $0.33 and non-GAAP diluted EPS of $0.36Operating income was $5.0 million and increased by 19%Announces third quarter and full year 2023 financial guidance WINTER SPRINGS, Fla.,...
WINTER SPRINGS, Fla., July 27, 2023 -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2023 second quarter financial results before the market opens on Thursday, August 3rd. Iradimed management will host a conference call the same...
WINTER SPRINGS, Fla., May 10, 2023 -- IRADIMED CORPORATION (the "Company") (NASDAQ: IRMD), was recently named on Forbes' latest list of America's Best Small Companies for 2023. Iradimed is a leader in the development of innovative magnetic resonance imaging ("MRI")...
Reports record revenue of $15.5 million for the first-quarter quarter of 2023 GAAP diluted EPS of $0.27 and non-GAAP diluted EPS of $0.30 Operating income was $4.0 million and increased by 30% Announces second quarter 2023 financial guidance and increases full-year...
WINTER SPRINGS, Fla., April 27, 2023 -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2023 first quarter financial results before the market opens on Thursday, May 4th. Iradimed management will host a conference call the same...
WINTER SPRINGS, Fla., March 06, 2023 -- IRADIMED CORPORATION (the "Company") (NASDAQ: IRMD) today announced that Roger Susi, President and Chief Executive Officer of the Company, will be presenting at the 35th Annual Roth Conference in Laguna Niguel, CA. Mr. Susi is...
Letter Notifying Customers of Potential Issues with MRidium 1057 MRI Syringe Adapter SetWINTER SPRINGS, Fla., Feb. 24, 2023 -- IRADIMED CORPORATION (the "Company") (NASDAQ: IRMD) issued an Urgent Medical Device Correction Letter to notify affected customers of a...
Reports fourth quarter 2022 revenue of $14.9 million, GAAP diluted EPS of $0.29 and non-GAAP diluted EPS of $0.32.Reports full-year 2022 revenue of $53.3 million, GAAP diluted EPS of $1.02 and non-GAAP diluted EPS of $1.10.The Board of Directors approved a special...